We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$522M
AUM Growth
+$177M
Cap. Flow
+$266M
Cap. Flow %
50.91%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
+$266M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVLO
1
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$215M 41.21%
+911,670
New +$266M
DNLI icon
2
Denali Therapeutics
DNLI
$3.67B
$136M 26.05%
8,918,749
– –
MCRB icon
3
Seres Therapeutics
MCRB
$48.1M
$109M 20.89%
634,144
– –
SYRS
4
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$32.7M 6.27%
320,444
– –
QTRX icon
5
Quanterix
QTRX
$173M
$29.2M 5.58%
2,030,495
– –

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q2 2018 Portfolio in Review

As of Q2 2018, Flagship Pioneering held 5 positions worth $522M, up 51% from $345M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering deployed $266M of net new capital in Q2 2018, opening 1 new position. Its largest new stake was Evelo Biosciences, Inc. Common Stock: 911,670 shares worth $215M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's largest Q2 2018 buy was Evelo Biosciences, Inc. Common Stock: 911,670 shares worth $215M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $522M portfolio in Q2 2018.
  • Flagship Pioneering opened 1 new position and closed 0 in Q2 2018.
  • Flagship Pioneering's portfolio value rose 51% quarter-over-quarter to $522M.

Based on Flagship Pioneering's 13F filing for Q2 2018, filed 7 Aug 2018.